Open access
Aug 2026
A primary human muscle cell-based assay for detecting myasthenia gravis autoantibody binding and assessing AChR cluster impairment
A physiologically relevant human NMJ model based on primary human muscle cells is established that enables detection and functional characterization of neuromuscular autoantibodies and a novel muscle cell-based assay (CBA) for the detection of neuromuscular autoantibodies is developed.
Marlene Wolfsgruber, Anna-Sophie Zimmermann, Katja Starnberger et al.
· bioRxiv · 0 citations